Increased production and assembly of extracellular matrix proteins during transdifferentiation of epithelial cells to a mesenchymal phenotype contributes to diseases such as renal and pulmonary fibrosis. TGF-b and hypoxia, two cues that initiate injury-induced fibrosis, caused human kidney cells to develop a mesenchymal phenotype, including increased fibronectin expression and secretion. However, upon hypoxia, assembled extracellular fibronectin fibrils were mostly absent, whereas treatment with TGF-b led to abundant fibrils. Fibrillogenesis required cell-generated force and tension. TGFb, but not hypoxia, increased cell contractility, as determined by phosphorylation of myosin light chain and quantifying force and tension generated by cells plated on engineered elastomeric microposts. Additionally, TGF-b, but not hypoxia, increased the activation of integrins. However, experimentally activating integrins markedly increased the levels of phosphorylated myosin light chain and fibronectin fibril assembly upon hypoxia. Our findings show that deficient integrin activation and subsequent lack of cell contractility are mechanisms that mediate a lack of fibrillogenesis upon hypoxia and they challenge current views on oxygen deprivation being sufficient for fibrosis.
INTRODUCTION
Fibrosis, the excessive accumulation of extracellular matrix proteins, is a consequence of sustained tissue injury. Tubulointerstitial fibrosis is a final common pathway in endstage chronic kidney diseases and is commonly seen with ischemic injury (Zeisberg and Kalluri, 2012; Campanholle et al., 2013; Leung et al., 2013) . Fibrosis also occurs in chronic obstructive lung diseases, including asthma, cystic fibrosis and hypertension (Chapman, 2011; Noble et al., 2012) . Fibrosis includes increased deposition of the extracellular matrix proteins fibronectin and collagen generated by proliferating resident fibroblasts and also by transdifferentiated epithelial cells that have undergone a fibrosis-associated type 2 epithelial-tomesenchymal transition (EMT) (Kalluri and Weinberg, 2009; Thiery et al., 2009 ). An EMT program contributes to hepatic (Teng et al., 2007; Zeisberg et al., 2007) , pulmonary (Kim et al., 2006; Chapman, 2011) and renal (Iwano et al., 2002; Liu, 2004; Higgins et al., 2007; Carew et al., 2012) fibrosis, although pericyte fibroblasts also contribute to renal (Lin et al., 2008; Humphreys et al., 2010) and pulmonary (Rock et al., 2011) fibrosis. A better understanding of the cellular responses leading to increased extracellular matrix deposition during EMT could improve therapeutic approaches for limiting fibrosis.
Extracellular cues initiating fibrosis in response to tissue injury include cytokines, such as transforming growth factor b (TGF-b), and hypoxia. Acute and chronic hypoxia promotes pulmonary (Voelkel et al., 2013) , renal (Higgins et al., 2007) and hepatic (Nath and Szabo, 2012) fibrosis. However, other than inducing sustained expression of the hypoxia inducible factor HIF1a (Haase, 2009) , the molecular and cellular mechanisms whereby hypoxia induces an EMT-like fibrosis remain unresolved. We show that although TGF-b and hypoxia induce an EMT-like transdifferentiation and increase extracellular fibronectin in clonal human HK2 kidney and A549 human lung adenocarcinoma cells, upon hypoxia, assembled extracellular fibronectin fibrils were mostly absent, although there were abundant fibrils upon TGF-b stimulation. Focusing on HK2 cells, which are derived from human adult kidney proximal tubule epithelium, we show that hypoxia is not sufficient to increase fibronectin matrix assembly owing to the lack of integrin activation and sufficient cell contractility to generate fibrils. Our findings provide important new insights on hypoxia-induced epithelial transdifferentiation that impact on current views and possibly therapeutic strategies for treating fibrotic disorders.
RESULTS AND DISCUSSION
Hypoxia increases the abundance, but not assembly, of extracellular fibronectin
We found marked differences in fibronectin deposited by HK2 cells with hypoxia compared with TGF-b. As previously reported (Miettinen et al., 1994; Hocevar et al., 2005; Haynes et al., 2011) , incubating HK2 cells with TGF-b (10 ng/ml; 48 h) induced a substantial increase in total cell-associated fibronectin (Fig. 1A) , as determined by immunoblotting cell lysates, and in the abundance of extracellular fibronectin (Fig. 1B) , as determined by immunolabeling extracellular fibronectin. Hypoxia (1% oxygen) for 48 h also increased the abundance of cell-associated fibronectin compared with normoxia controls (Fig. 1A) , in agreement with previous findings (Ryu et al., 2010; Lee et al., 2011) , and increased the abundance of extracellular fibronectin (Fig. 1B) . However, TGF-b induced a pronounced fibrillar assembly of extracellular fibronectin that was mostly absent upon hypoxia. The hypoxia mimetic dimethyloxaloylglycine (DMOG) also increased extracellular fibronectin but gave limited fibril assembly (supplementary material Fig. S1A ). We obtained similar results using human lung alveolar A549 cells, which undergo EMT upon exposure to TGF-b (Haynes et al., 2011) and hypoxia (Shin et al., 2012) . Although EMT of A549 cells upon hypoxia took 7 days, as indicated by increased fibronectin and actin stress fibers, the fibronectin fibrils seen with TGF-b were mostly absent (supplementary material Fig. S1B ). Cell-associated fibronectin is initially soluble in 2% deoxycholate (DOC) but when assembled into mature fibrils is DOC insoluble (McKeown-Longo and Mosher, 1983) . For HK2 cells, we confirmed by immunoblotting that a substantial proportion of fibronectin with TGF-b, but not upon hypoxia, was DOC-insoluble (Fig. 1C,D) .
We used two approaches to show that responses to hypoxia were independent of TGF-b. First, a luciferase assay performed with mouse lung endothelial cells (MLECs) expressing a truncated PAI-1 promoter that is activated by TGF-b (Abe et al., 1994) revealed that secreted latent and active TGF-b were not different upon hypoxia to those in normoxia controls (supplementary material Fig. S2 ). Second, blocking TGF-b signaling with SB431542, a pharmacological inhibitor of the TGF-b receptor type 1 (Laping et al., 2002) , markedly reduced the increase in assembled fibronectin with recombinant TGF-b but had no effect on increased fibronectin upon hypoxia (Fig. 1E ). These findings are in agreement with a previous report showing that hypoxia increases the proximal tubular cell matrix production independently of TGF-b (Orphanides et al., 1997) . Hence, hypoxia increases extracellular fibronectin independently of TGF-b receptor activation, and unlike the response to TGF-b, does not substantially increase the assembly of a fibrillar matrix.
Insufficient cell contractility contributes to attenuated fibronectin assembly with hypoxia
The assembly of a fibronectin matrix with TGF-b but not with hypoxia suggested that there are differences in the transdifferentiation process initiated by these two cues. We confirmed both cues increased expression of the transcription factor Snail1 (also known as Snai1) ( Fig. 2A,B) , an established marker for EMT (Kalluri and Weinberg, 2009) , although the abundance of Snail1 upon hypoxia was less than with TGF-b. In transgenic mice, increasing Snail1 in the adult kidney is sufficient to induce renal fibrosis (Boutet et al., 2006) . Decreased expression of E-cadherin is also a conserved marker of EMT (Kalluri and Weinberg, 2009; Thiery et al., 2009 ); however, the low level of E-cadherin expression in undifferentiated HK2 cells prevented us from assessing this marker. N-cadherin, which is expressed in control HK2 cells, increased with TGF-b and upon hypoxia ( Fig. 2A,C) , further confirming transdifferentiation is mediated by both cues. Expression of N-cadherin and the low abundance of E-cadherin suggest that HK2 cells do not have a 'ground state' epithelial phenotype; however increased expression of fibronectin, Snail1 and N-cadherin with TGF-b and upon hypoxia indicate transdifferentiation towards a mesenchymal phenotype.
Transdifferentiation of renal cells increases cell contractility (Fan et al., 2007) , and actomyosin contractility is essential for fibrillogenesis to generate mechanical tension that stretches compact soluble fibronectin molecules and unmasks selfassociation sites for fibril assembly (Leiss et al., 2008; Singh et al., 2010) . We found that hypoxia did not increase actomyosin contractility. Immunoblotting cell lysates for phosphorylated myosin light chain (pMLC-Thr18/Ser19; the antibody is specific for phosphorylated MYL2) showed increased abundance with TGF-b but not upon hypoxia compared with normoxia ( Fig. 2A,D) . We directly measured the contractility of cells plated on micromolded elastomeric microposts that deflect with cellgenerated force and tension as described previously (Fu et al., 2010) . We used cells expressing LifeAct-GFP, an actin filament reporter (Riedl et al., 2008; Haynes et al., 2011) , to identify cells on the fabricated arrays (Fig. 2E) . Compared with normoxia controls, TGF-b significantly increased cell contractility, as determined by measuring total force (nN) (Fig. 2F ) and traction energy (fJ) (Fig. 2G) . In contrast, total force and traction energy upon hypoxia were not significantly different than in normoxia controls (Fig. 2F,G) . Hence, although both TGF-b and hypoxia induce transdifferentiation of HK2 cells, cell contractility increases with TGF-b but not upon exposure to hypoxia.
If limited cell contractility is a determinant in attenuated fibrillogenesis upon hypoxia, we predicted that increasing contractility might increase the assembly of deposited fibronectin. We confirmed this prediction by transiently expressing in HK2 cells a mutant expressing phosphomimetic MLC containing aspartic acid substitutions for threonine 18 and serine 19 (MLC-DD), which renders MLC constitutively active and increases cell contractility (Yoneda et al., 2007) . MLC wild type (WT) and DD were tagged at the C-terminus with GFP to visualize expression in HK2 cells and extracellular fibronectin was determined by immunolabeling (Fig. 3) . Neither MLC construct changed the fibronectin abundance in normoxia controls. Upon hypoxia treatment, there were substantially more fibronectin fibrils with expression of MLC-DD but not MLC-WT (Fig. 3) . These findings are in agreement with a previous report showing that fibronectin assembly requires MLC activity (Yoneda et al., 2007) , and they indicate that limited cell contractility is at least in part a cause for defective fibrillogenesis upon exposure to hypoxia.
Lack of integrin activation is a mechanism for attenuated fibronectin assembly upon hypoxia Activation of integrin receptors increases fibrillogenesis and actomyosin contractility (Leiss et al., 2008; Singh et al., 2010) and mediates TGF-b-induced fibrosis (Henderson and Sheppard, 2013) . We predicted that lack of integrin activation might be a mechanism for limited cell contractility and fibronectin assembly upon hypoxia. Consistent with this prediction, the abundance of activated b1 integrin relative to total b1 integrin, as determined by immunoblotting, was significantly greater with TGF-b but not hypoxia compared with normoxia controls (Fig. 4A,B) . We did find that hypoxia but not TGF-b increased total b1 integrin expression, as previously reported (Cowden Dahl et al., 2005; Keely et al., 2009; Lee et al., 2011) . Additionally, both hypoxia and TGF-b increased total a5 integrin expression, as determined by immunoblotting cell lysates (supplementary material Fig.  S3A,B) , and the abundance of a5 integrin at the cell surface, as determined by fluorescence-activated cell sorting (FACS) (supplementary material Fig. S3C) . Hence, the lack of b1 integrin activation upon hypoxia is not due to limited a5b1 expression. Adding MnCl 2 (25 mM), which activates integrins (Ni et al., 1998) , significantly increased the abundance of activated b1 integrin relative to total b1 integrin as well as the levels of pMLC with normoxia and hypoxia ( Fig. 4A-D) . Additionally, although hypoxia increased a5 and b1 integrin expression, it did not increase integrin signaling, as indicated by the levels of phosphorylated focal adhesion kinase (FAK, also known as PTK2, denoted pFAK-Y397), which increases with integrin activation. In contrast pFAK-Y397 but not total FAK markedly increased with TGF-b and upon normoxia and hypoxia in the presence of MnCl 2 (Fig. 4E,F) . Additionally, MnCl 2 induced the assembly of extracellular fibronectin fibrils upon normoxia and hypoxia (Fig. 4G) , indicating that secreted fibronectin upon hypoxia is assembly competent. These findings reveal that hypoxia-induced epithelial transdifferentiation of HK2 cells leads to insufficient integrin activation, which is a likely determinant for deficient assembly of fibronectin and myosinbased contractility.
Our study shows that although hypoxia induces transdifferentiation of epithelial cells, as indicated by increased abundance of Snail1, N-cadherin and fibronectin, it does not induce a marked assembly of a fibrillar fibronectin matrix like that seen with TGF-b. These findings, which would be difficult to reveal in an animal model, suggest that hypoxia might not be sufficient to induce fibrosis in the absence of other cues such as an inflammatory response, although future studies are necessary to determine the effects of hypoxia on collagen deposition. Our data support a revised view on the role of hypoxia in a fibronectin fibrosis and indicate, as previously suggested (Haase, 2009) , that a synergism between hypoxia and TGF-b signaling might be necessary.
MATERIALS AND METHODS

Cell culture
Clonal human HK2 cells (American Type Cell Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) with Hams F-12 containing 4.5 g/l glucose and supplemented with 10% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin in a humidified incubator at 37˚C in an atmosphere of 5% CO 2 and 95% air (normoxic conditions). For transdifferentiation, HK2 cells were maintained for 48 h in serum-and Ca
2+
-free keratinocyte medium (Invitrogen) supplemented with 25 mg/ml bovine pituitary extract and 0.2 ng/ml epidermal growth factor. Human lung A549 adenocarcinoma cells (obtained from Harold Chapman, University of California, San Francisco, CA) were maintained in DMEM (4.5 g/l glucose) supplemented with 10% FBS (Invitrogen), 100 U/ml penicillin and 100 mg/ml streptomycin as described previously (Haynes et al., 2011) , with transdifferentiation determined in serum-free small airway basal medium (Lonza, Basel, Switzerland). Transdifferentiation was induced by adding recombinant TGF-b (PeproTech, Rocky Hill, NJ) (10 ng/ml for HK2 cells and 5 ng/ml for A549 cells) to the medium of normoxic cells and hypoxia was induced by incubating cells in a humidified modular incubator chamber (HeraCell 240i, Thermo Scientific, Waltham, MA) at 37˚C in an atmosphere of 1% O 2 , 5% CO 2 and 94% N 2 . Where indicated, the TGF-b receptor inhibitor SB431542 (5 mM; Sigma-Aldrich) was added when initiating transdifferentiation. Also where indicated, HK2 cells were transfected with cDNA encoding GFP-tagged MLC-WT and MLC-DD provided by Atsuko Yoneda, (Tokyo University of Pharmacy and Life Sciences, Japan) by using Lipofectamine 2000 (Invitrogen).
Immunolabeling
For labeling extracellular fibronectin, cells plated on acid-washed glass coverslips were incubated with anti-fibronectin antibodies (SigmaAldrich) for 1 h at 37˚C, washed in PBS and fixed with 4% formaldehyde for 12 min. Fixed cells were permeabilized with 0.2% Triton X-100 for 5 min, incubated with 3% BSA in PBS for 30 min and then incubated for 1 h with Alexa-Fluor-488-or Alexa-Fluor-568-conjugated secondary antibodies (Invitrogen). Actin filaments were labeled with Rhodamine-phalloidin (Invitrogen) added during secondary antibody incubations. Nuclei were stained with Hoechst 33342 (Invitrogen) added to the final wash. Cells were imaged using a 63˚Plan-Apochromat 1.40 NA or a 40˚EC Plan-Neofluar 1.30 NA oil immersion objective on a laser-scanning confocal microscope (Zeiss LSM510 META) or a spinning-disk confocal microscopy using a 406 Plan-fluor ELWD 0.6 NA air objective (phase contrast) or a 606 Plan Apochromat TIRF 1.45 NA oil immersion objective on an inverted microscope system (Nikon Eclipse TE2000 Perfect Focus System; Nikon Instruments, Melville, NY) equipped with a spinning-disk confocal scanner unit (CSU10; Yokogawa, Newnan, GA), a 488-nm solid-state laser (LMM5; Spectral Applied Research), a multipoint stage (MS-2000; Applied Scientific Instruments), a CoolSnap HQ2 cooled charge-coupled camera (Photometrics,) and camera-triggered electronic shutters controlled with NIS-Elements Imaging Software (Nikon). Images were processed using NIS-Elements.
Immunoblotting
Proteins in cell lysates obtained in a RIPA buffer were resolved by SDS-PAGE and transferred onto PVDF membranes (Millipore, Haywood, CA) as previously described (Haynes et al., 2011) . Activated b1 integrin was determined using samples prepared and resolved under non-reducing conditions as previously described (Du et al., 2011) . Membranes were blocked with 5% non-fat milk or 5% BSA and incubated with primary antibodies for 1 h at room temperature. Primary antibodies included fibronectin and a-tubulin (Sigma-Aldrich), Snail-1 and pMLC-Thr18/ Ser19 (Cell Signaling Technologies), FAK (BD Transduction Labs), pFAK-Y397 (Invitrogen), b1-integrin (12G10; Abcam), activated b1 integrin (HUTS-4; Millipore) and a5 integrin (Cell Signaling). After washing, membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) for 1 h at room temperature and immunoreactivity visualized with enhanced femto chemiluminescence (Thermo Scientific) and imaged using a BioRad Chemidoc XRS. BioRad Chemidoc XRS Image Lab software was used for semi-quantitative densitometric analysis of immunoblots. Immunoblotting DOC-soluble and -insoluble fibronectin was performed as described previously (McKeown-Longo and Mosher, 1983) using cells lysed in buffer containing 20 mM Tris-HCl pH 8, 2 mM EDTA, 2 mM iodoacetic acid, 2 mM N-ethylaleimide and 2% DOC. Lysates were centrifuged at 20,000 g for 20 min at 4˚C. The DOCinsoluble pellet was resuspended in DOC buffer containing 1% SDS. Proteins in the pellet and DOC-soluble supernatant were separated by SDS-PAGE and probed with anti-fibronectin antibodies.
Luciferase assays
The abundance of secreted TGF-b was determined using MLECs stably expressing a truncated promoter of PAI-1 fused to the firefly luciferase reporter gene as described previously (Abe et al., 1994; Karydis et al., 2009) . Conditioned medium collected from normoxic and hypoxic cells was applied to MLECs, for determining active TGF-b, or was heated at 80˚C for 10 min before applying, for determining secreted latent TGF-b. After 24 h MLEC extracts were assayed for luciferase activity using the Luciferase assay system (Promega, Madison, WI) according to the manufacturer's instructions, and luminescence was measured using a Spectramax M5 (Molecular Devices, Sunnyvale, CA) and expressed as relative luciferase units (RLU).
Measurement of cell contractility
HK2 cells stably expressing LifeAct-GFP were plated on micromolded PDMS micropost arrays (Fu et al., 2010) and cells were left untreated (normoxia controls), treated with TGF-b or subjected to hypoxia for 48 h. Cells were imaged at 37˚C using a 606 Plan Apochromat TIRF 1.45 NA oil immersion objective (for fluorescence) on a Nikon spinning-disk confocal microscope, as described for immunolabeling, enclosed in an environmental chamber maintained at 37˚C with 5% CO 2 . Images of the D9-DiI-stained (red channel) PDMS microposts were acquired at two different focal planes, at the top with the focal plane passing through the top surfaces of the microposts and at the bottom ,1 mm above the base of the microposts. The two images were analyzed with a customdeveloped Matlab program to calculate traction forces (Fu et al., 2010; Yang et al., 2011) .
FACS
Trypsinized cells were washed twice (PBS, 2% FBS, 0.1 azide) with centrifugation, resuspended at a concentration of 10 6 cells/ml in PBS with 2% FBS containing anti-a5-integrin antibodies (1 mg/ml; MAB1956Z clone P1D6, Millipore), transferred to polypropylene FACS tubes and incubated on ice for 30 min. Cells were washed by pelleting, resuspended in 1 ml of PBS with 3% BSA containing goat antimouse-IgG antibody conjugated to Alexa Fluor 488, incubated for 30 min on ice, washed, and fixed with 1% paraformaldehyde for 15 min. After washing (PBS with 3% FBS), cell pellets were resuspended in 0.5 ml of PBS with 3% BSA and used for FACS analysis to determine levels of cell surface a5 integrin.
